DK1441705T3 - Faste, stabiliserede terapeutiske systemer med hurtig og/ellermodificeret frigivelse til oral indgivelse af flydende aktive stoffer,hjælpestoffer eller fødevarer - Google Patents

Faste, stabiliserede terapeutiske systemer med hurtig og/ellermodificeret frigivelse til oral indgivelse af flydende aktive stoffer,hjælpestoffer eller fødevarer

Info

Publication number
DK1441705T3
DK1441705T3 DK02787578.0T DK02787578T DK1441705T3 DK 1441705 T3 DK1441705 T3 DK 1441705T3 DK 02787578 T DK02787578 T DK 02787578T DK 1441705 T3 DK1441705 T3 DK 1441705T3
Authority
DK
Denmark
Prior art keywords
foods
excipients
stabilized
rapid
solid
Prior art date
Application number
DK02787578.0T
Other languages
English (en)
Inventor
Maria Gabriella Massironi
Original Assignee
Farmatron Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmatron Ltd filed Critical Farmatron Ltd
Application granted granted Critical
Publication of DK1441705T3 publication Critical patent/DK1441705T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK02787578.0T 2001-11-09 2002-11-06 Faste, stabiliserede terapeutiske systemer med hurtig og/ellermodificeret frigivelse til oral indgivelse af flydende aktive stoffer,hjælpestoffer eller fødevarer DK1441705T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2001MI002366A ITMI20012366A1 (it) 2001-11-09 2001-11-09 Sistemi terapeutici stabilizzati a rilascio immediato e/o modificato per la somministrazione orale di principi attivi e/o eccipienti e/o ali
PCT/EP2002/012364 WO2003039521A1 (en) 2001-11-09 2002-11-06 Solid, stabilized, prompt- and/or modified-release therapeutical systems for the oral administration of liquid active principles, excipients or foodstuffs

Publications (1)

Publication Number Publication Date
DK1441705T3 true DK1441705T3 (da) 2014-11-03

Family

ID=11448588

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02787578.0T DK1441705T3 (da) 2001-11-09 2002-11-06 Faste, stabiliserede terapeutiske systemer med hurtig og/ellermodificeret frigivelse til oral indgivelse af flydende aktive stoffer,hjælpestoffer eller fødevarer

Country Status (11)

Country Link
US (1) US20050037068A1 (da)
EP (1) EP1441705B1 (da)
JP (1) JP2005508982A (da)
AU (1) AU2002351850B2 (da)
CA (1) CA2466529C (da)
CY (1) CY1115707T1 (da)
DK (1) DK1441705T3 (da)
ES (1) ES2515790T3 (da)
IT (1) ITMI20012366A1 (da)
PT (1) PT1441705E (da)
WO (1) WO2003039521A1 (da)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003024430A1 (en) 2001-09-21 2003-03-27 Egalet A/S Morphine polymer release system
US20040234602A1 (en) 2001-09-21 2004-11-25 Gina Fischer Polymer release system
IS1935B (is) * 2002-03-19 2004-06-16 Actavis Group Hf. Fósínópríl lyfjasamsetning
US7423004B2 (en) * 2003-01-31 2008-09-09 Smithkline Beecham Corporation Solid dispersion compositions
US20070196396A1 (en) * 2004-02-11 2007-08-23 Rubicon Research Private Limited Controlled release pharmaceutical compositions with improved bioavailability
US20060134212A1 (en) * 2004-09-02 2006-06-22 Forest Laboratories, Inc. Lercanidipine immediate release compositions
US20060165789A1 (en) * 2004-09-09 2006-07-27 Forest Laboratories, Inc. Lercanidipine modified release compositions
US20060165788A1 (en) * 2004-09-09 2006-07-27 Wattanaporn Abramowitz Lercanidipine pH dependent pulsatile release compositions
CN101188999B (zh) * 2005-06-03 2012-07-18 尹格莱特股份有限公司 用于递送分散在分散介质中的活性物质的药物传递系统
BRPI0618455A2 (pt) 2005-11-11 2011-08-30 Mochida Pharm Co Ltd composição de geléia
GB0524961D0 (en) * 2005-12-07 2006-01-18 Pharmakodex Ltd Transdermal administration of active agents for systemic effect
HUE029572T2 (en) 2006-02-03 2017-03-28 Opko Renal Llc Treatment of Vitamin D Insufficiency and Deficiency with 25-Hydroxy-D2 and 25-Hydroxy-D3
US8329677B2 (en) 2006-06-21 2012-12-11 Cytochroma, Inc. Method of treating and preventing secondary hyperparathyroidism
EP2051696A2 (en) * 2006-08-18 2009-04-29 Morton Grove Pharmaceuticals, Inc. Stable liquid levetiracetam compositions and methods
EP1952806A1 (en) 2007-02-01 2008-08-06 Helm AG Process for the preparation of adsorbates of candesartan
KR101495578B1 (ko) 2007-04-25 2015-02-25 사이토크로마 인코포레이티드 비타민 ｄ 부족 및 결핍의 치료 방법
WO2008134518A2 (en) 2007-04-25 2008-11-06 Cytochroma Inc. Methods and compounds for vitamin d therapy
EP3542792B1 (en) 2007-04-25 2023-06-28 EirGen Pharma Ltd. Controlled release 25-hydroxyvitamin d
WO2008134523A1 (en) 2007-04-25 2008-11-06 Proventiv Therapeutics, Llc Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease
NZ580972A (en) 2007-06-04 2012-02-24 Egalet Ltd Controlled release pharmaceutical compositions for prolonged effect
EP2220208A4 (en) * 2007-11-23 2010-12-29 Rappaport Family Inst For Res USE OF HAPTOGLOBIN GENOTYPING IN THE DIAGNOSIS AND TREATMENT OF CARDIOVASCULAR DISEASE
KR101852042B1 (ko) 2008-04-02 2018-04-25 사이토크로마 인코포레이티드 비타민 ｄ 결핍 및 관련 장애에 유용한 방법, 조성물, 용도 및 키트
SI2165702T1 (sl) 2008-09-17 2012-05-31 Helm Ag Stabilni in z lahkoto raztopljeni sestavki kandesartan cileksetila pripravljeni z vlažno granulacijo
CA2751667C (en) 2009-02-06 2016-12-13 Egalet Ltd. Immediate release composition resistant to abuse by intake of alcohol
EP2445487A2 (en) 2009-06-24 2012-05-02 Egalet Ltd. Controlled release formulations
JP5663025B2 (ja) 2009-09-15 2015-02-04 キューエルティー インコーポレイテッド ９−ｃｉｓ−レチニルエステルを脂質ビヒクル中に含む医薬製剤
WO2011121989A1 (ja) * 2010-03-29 2011-10-06 株式会社カネカ 被覆用油脂組成物及びそれを用いた粒子状組成物
LT2552484T (lt) 2010-03-29 2020-04-27 Opko Ireland Global Holdings, Ltd. Būdai ir kompozicijos, skirti paratiroidų lygiams sumažinti
RU2622763C2 (ru) 2010-04-19 2017-06-19 Новелион Терапьютикс Инк. Лечебная схема и способы лечения или уменьшения нарушений зрения, связанных с дефицитом эндогенных ретиноидов
CN102552923A (zh) * 2012-01-31 2012-07-11 辽宁思百得医药科技有限公司 包含左卡尼汀和辅酶q10的药物组合物及其制备方法
WO2013134867A1 (en) 2012-03-01 2013-09-19 Qlt Inc. Therapeutic regimens and methods for improving visual function in visual disorders associated with an endogenous retinoid deficiency
CA2877183A1 (en) 2012-07-06 2014-01-09 Egalet Ltd. Abuse deterrent pharmaceutical compositions for controlled release
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
US9375033B2 (en) 2014-02-14 2016-06-28 R.J. Reynolds Tobacco Company Tobacco-containing gel composition
CN114681468A (zh) 2014-08-07 2022-07-01 欧普科爱尔兰环球控股有限公司 利用25-羟基维生素d的辅助疗法
KR101710441B1 (ko) * 2015-12-28 2017-02-28 신풍제약주식회사 안정성 및 용출성이 향상된 정제
US9675585B1 (en) 2016-03-24 2017-06-13 Ezra Pharma Extended release pharmaceutical formulations
US9687475B1 (en) 2016-03-24 2017-06-27 Ezra Pharma Llc Extended release pharmaceutical formulations with controlled impurity levels
TW202214257A (zh) 2016-03-28 2022-04-16 愛爾蘭商歐科愛爾蘭全球控股股份有限公司 維生素d治療之方法
GB201716419D0 (en) 2017-10-06 2017-11-22 Univ Central Lancashire Solid composition

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6112632A (ja) * 1984-06-27 1986-01-21 Eisai Co Ltd 脂溶性薬剤含有組成物
NL8701335A (nl) * 1986-06-21 1988-01-18 Sandoz Ag Orale farmaceutische preparaten.
LU87416A1 (fr) * 1988-12-29 1990-07-10 Cird Microgranules charges en une substance active,constitues essentiellement d'un triglyceride d'acides gras satures et leur utilisation par voie topique dans le domaine therapeutique
TW209174B (da) * 1991-04-19 1993-07-11 Takeda Pharm Industry Co Ltd
US5800834A (en) * 1996-06-10 1998-09-01 Spireas; Spiridon Liquisolid systems and methods of preparing same
PT1017390E (pt) * 1997-07-31 2007-07-24 Kos Life Sciences Inc Comprimido revestido que compreende ácido nicotínico ou um composto metabolizado a ácido nicotínico sob uma forma de libertação prolongada, e um revestimento que contém um inibidor da hmg-coa-redutase sob uma forma de libertação imediata.
JPH11152220A (ja) * 1997-11-19 1999-06-08 Daiichi Yakuhin Kogyo Kk 脂溶性薬物を含有した丸剤の製造方法
FR2779651B1 (fr) * 1998-06-16 2001-04-20 Gattefosse Ets Sa Procede pour la fabrication de comprimes a liberation prolongee de principe(s) actif(s) presentant une cinetique de dissolution d'ordre zero
FR2785198B1 (fr) * 1998-10-30 2002-02-22 Rhodia Chimie Sa Granules redispersables dans l'eau comprenant une matiere active sous forme liquide
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
WO2000076478A1 (en) * 1999-06-14 2000-12-21 Cosmo S.P.A. Controlled release and taste masking oral pharmaceutical compositions
US6525058B1 (en) * 1999-06-18 2003-02-25 Yamanouchi Pharmaceutical Co., Ltd Pharmaceutical composition for oral use
DE19954923A1 (de) * 1999-11-16 2001-05-17 Bitec Gmbh Verfahren zur Herstellung von gereinigten Pulvern sowie danach erhältliche Pulver
US6793934B1 (en) * 1999-12-08 2004-09-21 Shire Laboratories, Inc. Solid oral dosage form
EP1116515A3 (en) * 2000-01-11 2002-08-21 Givaudan SA Encapsulated liquid

Also Published As

Publication number Publication date
CY1115707T1 (el) 2017-01-25
PT1441705E (pt) 2014-10-20
ITMI20012366A1 (it) 2003-05-09
EP1441705B1 (en) 2014-09-03
JP2005508982A (ja) 2005-04-07
CA2466529C (en) 2012-07-10
US20050037068A1 (en) 2005-02-17
EP1441705A1 (en) 2004-08-04
ES2515790T3 (es) 2014-10-30
WO2003039521A1 (en) 2003-05-15
CA2466529A1 (en) 2003-05-15
AU2002351850B2 (en) 2008-01-24

Similar Documents

Publication Publication Date Title
DK1441705T3 (da) Faste, stabiliserede terapeutiske systemer med hurtig og/ellermodificeret frigivelse til oral indgivelse af flydende aktive stoffer,hjælpestoffer eller fødevarer
DK1181027T3 (da) Diætetisk eller farmaceutisk præparat til anvendelse til forebyggelsen eller behandling af hyperoxaluri
DK1957110T3 (da) Fremgangsmåde til fremstilling af tygbare doseringsformer til lægemiddeladministration og produkter dermed
HK1068539A1 (en) Pharmaceutical containing 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol and providing delayed release of the active ingredient
DK0956858T3 (da) Farmaceutiske præparater indeholdende lactobacilli til behandling af vaginale infektioner
NO20024734D0 (no) Farmasöytisk preparat for behandling av akutt, kronisk smerte og/eller neuropatisk smerte og migrener
EE05506B1 (et) Ravimi manustamise vahend eriti progestiinide ja”strogeenide manustamiseks
AU2003280087A8 (en) Dosage forms for increasing the solubility and extending the release of drugs such as e.g. topiramate and phenyton
AU2002349001A1 (en) Pharmaceutical containing 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol and providing delayed release of the active ingredient
DK1478339T3 (da) Farmaceutiske formuleringer af antineoplastiske midler, specielt temozolomid, fremgangsmåder til fremstilling og anvendelse heraf
DK1093370T3 (da) Farmaceutisk præparat til behandling af diabetes
NO20043309L (no) Legemiddelleveringssystemer for hindring og behandling av vaskulaere sykdommer som innbefatter rapamycin og derivater derav
AU6311301A (en) Drug/drug delivery systems for the prevention and treatment of vascular disease
NO993383L (no) Ekspanderbart gastro-retentivt terapeutisk system med kontrollert frigiving av aktivt stoff i gastro-intestinaltrakten
DK1368004T3 (da) Mucoadhæsiv dispergeringsdygtig farmaceutisk fremstilling til administrering af aktivt middel i veterinærmedicin og human medicin
BRPI0209720A2 (pt) dosagem e embalagem de medicação com liberação controlada
IS7065A (is) Áætlun um lyfjaskammta við meðferð og lyfjasamsetningar til getnaðarvarna í neyð
NO20026212L (no) Forbindelse for medikamentavleveringssystem og fremgangsmåte for fremstilling av forbindelsen
EA200600603A1 (ru) Оральная система доставки лекарственного препарата
IT1319210B1 (it) Pellicola per la somministrazione dermica e transdermica di principiattivi.
NO20044132L (no) Legemidler som inneholder aktive ingredienser som senker kolesterolnivaet med tidsforsinket frigjoring av det aktive middelet
DK1178799T3 (da) Gastrobeskyttede mikrogranula, fremgangsmåde til opnåelse af samme og farmaceutiske præparater
DZ3459A1 (fr) Derives de 2h-1-benzopyran, procedes de preparation de ces derniers et compositions pharmaceutiques dans lesquels ils entrent.
WO2002034240A3 (en) Delayed and sustained release formulations and method of use thereof
DK1064284T3 (da) Hypnotiske beta-carbolinderivater, fremgangsmåde til fremstilling deraf og deres anvendelse som medicinske produkter